艾曲波帕片原研说明书.pdfVIP

HIGHLIGHTS OF PRESCRIBING INFORMATION • Chronic ITP: Initiate PROMACTA at 50 mg once daily for most patients. These highlights do not include all the information needed to use Reduce initial dose in patients with hepatic impairment and/or patients of PROMACTA safely and effectively. See full prescribing information for East Asian ancestry. Adjust to maintain platelet count greater than or equal PROMACTA. to 50 x 109/L. Do not exceed 75 mg per day. (2.1) • Chronic Hepatitis C-associated Thrombocytopenia: Initiate PROMACTA (eltrombopag) tablets, for oral use PROMACTA at 25 mg once daily for all patients. Adjust to achieve target Initial U.S. Approval: 2008 platelet count required to initiate antiviral therapy. Do not exceed a daily dose of 100 mg. (2.2) WARNING: RISK FOR HEPATIC DECOMPENSATION IN PATIENTS • Severe Aplastic Anemia: Initiate PROMACTA at 50 mg once daily for WITH CHRONIC HEPATITIS C most patients. Reduce initial dose in patients with hepatic impairment or patients of East Asian ancestry. Adjust to maintain platelet count greater See full prescribing information for complete boxed warning